Render Target: STATIC
Render Timestamp: 2024-10-25T10:55:38.388Z
Commit: 56767fe525c928647c8401233a175d0d607d385d
XML generation date: 2024-09-19 21:57:39.552
Product last modified at: 2024-09-30T19:15:07.544Z
View Featured Offers >>
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72
  1. Products /
  2. Activators & Inhibitors /
  3. Trametinib

Trametinib #62206

    Product Information

    Product Usage Information

    Trametinib is supplied as a lyophilized powder. For a 15 mM stock, reconstitute 10 mg of powder in 1.08 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 615.4 g/mol
    Purity >98%
    Molecular Formula C26H23FIN5O4
    CAS 871700-17-3
    Solubility Soluble in DMSO at 20 mg/ml with slight warming.

    Background

    Trametinib, also known as GSK1120212, is a potent and selective inhibitor of MEK with an IC50 of 0.7 nM for u-MEK1 and 14.9 nM for pp-MEK1 (1). When compared to several tyrosine kinase inhibitors (TKIs) and MEK inhibitors (MEKIs) in endothelial cells, Trametinib displays the highest level of antiangiogenic activity and is the most effective ERK1/2 inhibitor (IC50 = 1.3 nM) (2). Trametinib has also been shown to be the most effective at reducing proliferation in low-grade serous ovarian cancers (LGSCs) when compared to other MEKIs (3).

    Limited Uses

    Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

    Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.